Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MG1-MAGEA3 |
Trade Name | |
Synonyms | |
Drug Descriptions |
MG1-MAGEA3 is a cancer vaccine comprising an oncolytic Maraba virus strain expressing MAGEA3, which may result in enhanced immune response against cells expressing the tumor-associated antigen (TAA) MAGEA3 (PMID: 30546947). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ad-MAGEA3 + MG1-MAGEA3 + Pembrolizumab | Ad-MAGEA3 MG1-MAGEA3 Pembrolizumab | 0 | 1 |
MG1-MAGEA3 | MG1-MAGEA3 | 0 | 0 |